If you made any changes in Pure these will be visible here soon.

Research Output

2020

Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial

Petrelli, F., Labianca, R., Zaniboni, A., Lonardi, S., Galli, F., Rulli, E., Rosati, G., Corallo, S., Ronzoni, M., Cardellino, G. G., Mattioli, R., Mambrini, A., Ciuffreda, L., Banzi, M., Pusceddu, V., Maiello, E., Zampino, M., Zagonel, V., Marchetti, P., Corsi, D. & 3 others, Rimassa, L., Cinieri, S. & Sobrero, A., Apr 2020, In : JAMA oncology. 6, 4, p. 547-551 5 p.

Research output: Contribution to journalArticle

Open Access

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., Ciarlo, A. & 11 others, Buonadonna, A., Silvestris, N., Piazza, E., Pavesi, L., Moroni, M., Clerico, M., Aglietta, M., Giordani, P., Galli, F., Galli, F. & Petrelli, F., Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12

Research output: Contribution to journalArticle

Open Access

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Philip, P. A., Lacy, J., Portales, F., Sobrero, A., Pazo-Cid, R., Manzano Mozo, J. L., Kim, E. J., Dowden, S., Zakari, A., Borg, C., Terrebonne, E., Rivera, F., Sastre, J., Bathini, V., López-Trabada, D., Asselah, J., Saif, M. W., Shiansong Li, J., Ong, T. J., Nydam, T. & 1 others, Hammel, P., Mar 2020, In : The Lancet Gastroenterology and Hepatology. 5, 3, p. 285-294 10 p.

Research output: Contribution to journalArticle

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

Yoshino, T., Cleary, J. M., Van Cutsem, E., Mayer, R. J., Ohtsu, A., Shinozaki, E., Falcone, A., Yamazaki, K., Nishina, T., Garcia-Carbonero, R., Komatsu, Y., Baba, H., Argilés, G., Tsuji, A., Sobrero, A., Yamaguchi, K., Peeters, M., Muro, K., Zaniboni, A., Sugimoto, N. & 12 others, Shimada, Y., Tsuji, Y., Hochster, H. S., Moriwaki, T., Tran, B., Esaki, T., Hamada, C., Tanase, T., Benedetti, F., Makris, L., Yamashita, F. & Lenz, H. J., Jan 2020, In : Annals of Oncology. 31, 1, p. 88-95 8 p.

Research output: Contribution to journalArticle

Open Access
2019

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y. J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., Sep 1 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183-191.e3

Research output: Contribution to journalArticle

Open Access

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clin Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Eng, C., Kim, T. W., Bendell, J., Argilés, G., Tebbutt, N. C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N. H., Sobrero, A., Yan, Y., Chang, I., Uyei, A., Roberts, L., Ciardiello, F., Ahn, J. B., Asselah, J., Badarinath, S., Baijal, S. & 30 others, Begbie, S., Berry, S., Canon, J. L., Carbone, R. G., Cervantes, A., Cha, Y. J., Chang, K., Chaudhry, A., Chmielowska, E., Cho, S. H., Chu, D., Couture, F., Cultrera, J., Cunningham, D., Van Cutsem, E., Cuyle, P. J., Davies, J., Dowden, S., Dvorkin, M., Ganju, V., Garcia, R. V., Kerr, R., Kim, T. Y., King, K., Kortmansky, J., Lam, K. O., Lee, J., Lee, A. S., Lesperance, B. & Maiello, E., 2019, In : The Lancet Oncology. 20, 6, p. 849-861 13 p.

Research output: Contribution to journalArticle

Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses

Lenz, H. J., Argiles, G., Yoshino, T., Lonardi, S., Falcone, A., Limón, M. L., Sobrero, A., Hastedt, C., Peil, B., Voss, F., Griebsch, I. & Van Cutsem, E., Dec 1 2019, In : Clinical Colorectal Cancer. 18, 4, p. 269-279.e 10 p.

Research output: Contribution to journalArticle

Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses

Lenz, H. J., Argiles, G., Yoshino, T., Lonardi, S., Falcone, A., Limón, M. L., Sobrero, A., Hastedt, C., Peil, B., Voss, F., Griebsch, I. & Van Cutsem, E., Dec 1 2019, In : Clinical Colorectal Cancer. 18, 4, p. 269-279.e 11 p.

Research output: Contribution to journalArticle

Open Access

HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer

Bregni, G., Sciallero, S. & Sobrero, A., May 1 2019, In : JAMA oncology. 5, 5, p. 605-606 2 p.

Research output: Contribution to journalComment/debate

Maximising clinical benefit with adequate patient management beyond the second line in mCRC

Argiles, G., Arnold, D., Prager, G., Sobrero, A. F. & Van Cutsem, E., May 1 2019, In : ESMO Open. 4, 2, e000495.

Research output: Contribution to journalReview article

Open Access

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., Apr 3 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 99.

Research output: Contribution to journalArticle

Open Access

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 30 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Scotti, V., Crinò, L., Marchetti, P., Scoppola, A., Favaretto, A., Mattioli, R., Bernardo, A., Di Lieto, M., Moroni, M., Lorusso, V. & Santoro, A., 2019, In : BJU International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme: BJU International

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 81 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferraù, F., Crinò, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Sorarù, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G. & Group, T. I. N. R. C. C. E. A. P., 2019, In : HSB International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 81 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferraù, F., Crinò, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Sorarù, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G. & Group, T. I. N. R. C. C. E. A. P., 2019, In : BJU International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Ruzzo, A., Graziano, F., Galli, F., Galli, F., Rulli, E., Lonardi, S., Ronzoni, M., Massidda, B., Zagonel, V., Pella, N., Mucciarini, C., Labianca, R., Ionta, M. T., Bagaloni, I., Veltri, E., Sozzi, P., Barni, S., Ricci, V., Foltran, L., Nicolini, M. & 9 others, Biondi, E., Bramati, A., Turci, D., Lazzarelli, S., Verusio, C., Bergamo, F., Sobrero, A., Frontini, L. & Magnani, M., Aug 8 2019, In : Sci. Rep.. 9, 1, p. 1-9 9 p., 11527.

Research output: Contribution to journalArticle

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

Ruzzo, A., Graziano, F., Galli, F., Galli, F., Rulli, E., Lonardi, S., Ronzoni, M., Massidda, B., Zagonel, V., Pella, N., Mucciarini, C., Labianca, R., Ionta, M. T., Bagaloni, I., Veltri, E., Sozzi, P., Barni, S., Ricci, V., Foltran, L., Nicolini, M. & 9 others, Biondi, E., Bramati, A., Turci, D., Lazzarelli, S., Verusio, C., Bergamo, F., Sobrero, A., Frontini, L. & Magnani, M., Dec 1 2019, In : Scientific Reports. 9, 1, 11527.

Research output: Contribution to journalArticle

Open Access

The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective

Bregni, G., Rebuzzi, S. E. & Sobrero, A., Jan 1 2019, In : Current Treatment Options in Oncology. 20, 1, 8.

Research output: Contribution to journalReview article

2018

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., Sep 1 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study

Pastorino, A., Di Bartolomeo, M., Maiello, E., Iaffaioli, V., Ciuffreda, L., Fasola, G., Di Costanzo, F., Frassineti, G. L., Marchetti, P., Antoniotti, C., Leone, F., Zaniboni, A., Aprile, G., Zilocchi, C., Sobrero, A. & Bordonaro, R., 2018, In : Clinical Colorectal Cancer. 17, 3, p. e457-e470

Research output: Contribution to journalArticle

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, K. K. H., Sørbye, H., Glimelius, B., Adams, R. A., André, T., Arnold, D., Berlin, J. D., Bodoky, G., de Gramont, A., Díaz-Rubio, E., Eng, C., Falcone, A., Grothey, A., Heinemann, V., Hochster, H. S., Kaplan, R. S., Kopetz, S., Labianca, R., Lieu, C. H., Meropol, N. J. & 12 others, Price, T. J., Schilsky, R. L., Schmoll, H. J., Shacham-Shmueli, E., Shi, Q., Sobrero, A. F., Souglakos, J., Van Cutsem, E., Zalcberg, J., van Oijen, M. G. H., Punt, C. J. A. & Koopman, M., Sep 1 2018, In : European Journal of Cancer. 100, p. 35-45 11 p.

Research output: Contribution to journalArticle

Duration of adjuvant chemotherapy for stage III colon cancer

Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J. A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J. P., Renfro, L. A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M. & 3 others, Sargent, D. J., Andre, T. & Iveson, T., Mar 29 2018, In : New England Journal of Medicine. 378, 13, p. 1177-1188 12 p.

Research output: Contribution to journalArticle

Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer

Bendell, J., Ciardiello, F., Tabernero, J., Tebbutt, N., Eng, C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N., Sobrero, A., Shi, Y., Roberts, L., Yan, Y., Chang, I., Uyei, A. & Kim, T., Jun 2018, In : Annals of Oncology. 29, p. v123

Research output: Contribution to journalArticle

Open Access

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

on behalf of the TOSCA Investigators, May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, O. B. O. T. TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

Locoregional Tumor Therapy

Van Cutsem, E., Vogl, T. J., Orsi, F. & Sobrero, A., Jan 1 2018, Springer International Publishing AG. 274 p.

Research output: Book/ReportBook

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): A phase III, international, randomized, placebo-controlled study

Van Cutsem, E., Yoshino, T., Lenz, H. J., Lonardi, S., Falcone, A., Limón, M. L., Saunders, M., Sobrero, A., Park, Y. S., Ferreiro, R., Hong, Y. S., Tomasek, J., Taniguchi, H., Ciardiello, F., Stoehr, J., Oum'hamed, Z., Vlassak, S., Studeny, M. & Argiles, G., Sep 1 2018, In : Annals of Oncology. 29, 9, p. 1955-1963 9 p.

Research output: Contribution to journalArticle

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): A phase III, international, randomized, placebo-controlled study

Van Cutsem, E., Yoshino, T., Lenz, H. J., Lonardi, S., Falcone, A., Limón, M. L., Saunders, M., Sobrero, A., Park, Y. S., Ferreiro, R., Hong, Y. S., Tomasek, J., Taniguchi, H., Ciardiello, F., Stoehr, J., Oum'hamed, Z., Vlassak, S., Studeny, M. & Argiles, G., Sep 1 2018, In : Annals of Oncology. 29, 9, p. 1955-1963 9 p.

Research output: Contribution to journalArticle

Prognostic value of neutrophil-lymphocite ratio in resected high risk colorectal cancer: An analysis of adjuvant TOSCA trial

Petrelli, F., Rosati, G., Banzi, M., Zampino, M. G., Pella, N., Di Bartolomeo, M., Maiello, E., Bidoli, P., Ferrari, D., Rimassa, L., Labianca, R., Scartozzi, M., Lonardi, S., de Placido, S., Zaniboni, A., Sobrero, A., Frassineti, L. G., Silvestris, N., Corsi, D., Galli, F. & 1 others, Barni, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii175

Research output: Contribution to journalArticle

Open Access

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J. F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A. & 3 others, Kalmus, J., Falcone, A. & Zaniboni, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J-F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A. & 3 others, Kalmus, J., Falcone, A. & Zaniboni, A., Sep 6 2018, In : The oncologist.

Research output: Contribution to journalArticle

Retrospective RAS analysis of the EPIC trial: Cetuximab plus irinotecan vs irinotecan in patients (pts) with second-line metastatic colorectal cancer (mCRC)

Sobrero, A., Lenz, H. J., Eng, C., Scheithauer, W., Middleton, G., Chen, W., Esser, R., Nippgen, J. & Burris, H., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii163

Research output: Contribution to journalArticle

Open Access